Pages that link to "Q30583493"
Jump to navigation
Jump to search
The following pages link to Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? (Q30583493):
Displaying 50 items.
- Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke (Q24555180) (← links)
- Cerebrospinal fluid may mediate CNS ischemic injury (Q24810607) (← links)
- Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia (Q26851322) (← links)
- Systematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic stroke (Q28073784) (← links)
- Management of acute stroke (Q28196668) (← links)
- BMS-204352: a potassium channel opener developed for the treatment of stroke (Q28217424) (← links)
- Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury (Q28750483) (← links)
- Prolonged but delayed postischemic hypothermia: a long-term outcome study in the rat middle cerebral artery occlusion model (Q30640104) (← links)
- Physiologically based model of acute ischemic stroke (Q30712546) (← links)
- Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo (Q31808143) (← links)
- A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke (Q31924104) (← links)
- New 5-HT1A receptor agonists possessing 1,4-benzoxazepine scaffold exhibit highly potent anti-ischemic effects. (Q32068390) (← links)
- Analysis of the XRCC1 gene as a modifier of the cerebral response in ischemic stroke (Q33262823) (← links)
- An analysis of methylenetetrahydrofolate reductase and glutathione S-transferase omega-1 genes as modifiers of the cerebral response to ischemia (Q33485594) (← links)
- Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms (Q33665291) (← links)
- Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials (Q33809873) (← links)
- Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders (Q33863397) (← links)
- NMDA receptor subunits: diversity, development and disease (Q33950711) (← links)
- Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury (Q33984607) (← links)
- A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke. (Q33995061) (← links)
- Ischemic penumbra: evidence from functional imaging in man. (Q34037705) (← links)
- The neurobiology and consequences of epilepsy in the developing brain (Q34167901) (← links)
- gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia (Q34216896) (← links)
- Immunosuppressants-ligands as neuroprotectants. (Q34264194) (← links)
- Mitochondria as target for antiischemic drugs (Q34264465) (← links)
- BAY 38-7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury. (Q34280204) (← links)
- Spontaneously hypertensive rats display reduced microglial activation in response to ischemic stroke and lipopolysaccharide (Q34286778) (← links)
- Hyperforin attenuates brain damage induced by transient middle cerebral artery occlusion (MCAO) in rats via inhibition of TRPC6 channels degradation (Q34311502) (← links)
- Neuroprotection for ischaemic stroke: an unattainable goal? (Q34313475) (← links)
- Investigation of AM-36: a novel neuroprotective agent (Q34434677) (← links)
- Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery (Q34480959) (← links)
- Mechanisms of acute brain injury after subarachnoid hemorrhage (Q34535638) (← links)
- Current status of neuroprotective agents in the treatment of acute ischemic stroke (Q34566325) (← links)
- Anti-ischemic effect of curcumin in rat brain (Q34587276) (← links)
- Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds (Q34658945) (← links)
- Seizure-induced damage in the developing human: relevance of experimental models. (Q34763848) (← links)
- Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions? (Q34771671) (← links)
- Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation (Q35015325) (← links)
- Glucocorticoids and central nervous system inflammation (Q35022584) (← links)
- Neuroprotective agents for the treatment of acute ischemic stroke (Q35036473) (← links)
- On the regulation of ischaemia-induced glutamate efflux from rat cortex by GABA; in vitro studies with GABA, clomethiazole and pentobarbitone. (Q35042403) (← links)
- Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a novel GPR30-dependent Mechanism (Q35072737) (← links)
- Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection (Q35082167) (← links)
- Altered responsiveness of the guinea-pig isolated ileum to smooth muscle stimulants and to electrical stimulation after in situ ischemia (Q35100669) (← links)
- Mechanisms, challenges and opportunities in stroke (Q35120144) (← links)
- Magnesium: potential roles in neurovascular disease (Q35159997) (← links)
- Animal models of stroke: do they have value for discovering neuroprotective agents? (Q35198028) (← links)
- Promising targets of cell death signaling of NR2B receptor subunit in stroke pathogenesis (Q35576381) (← links)
- Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders (Q35915801) (← links)
- Erythropoietin: novel approaches to neuroprotection in human brain disease (Q35956310) (← links)